Shares of Synergy Pharmaceuticals are Falling Today and This is Why
On August 10, Synergy Pharmaceuticals (NASDAQ:$SGYP) shares dropped as much as 13% in early morning trade. Why? The commercial-stage biopharmaceutical company reported a much higher loss than what Wall Street was expecting. Even though Synergy …
Mylan N.V. Lowers 2017 Forecast Due to Delays in New Drugs
On August 9, American pharmaceutical company Mylan N.V. (NASDAQ:$MYL) announced that delays in launching key new drugs and deteriorating prices for generics in the U.S. will hurt its profitability tremendously in 2017 and 2018. As …
Shares of Surgery Partners Plummeted Today and This is Why
If you’re a healthcare investor, pay close attention to the following: On Wednesday, shortly after the opening bell, shares of Surgery Partners Inc. (NASDAQ:$SGRY) dropped 52%. Why? It was in response to an earnings miss …
PDL BioPharma Shares Increased Today, But Investors Remain Skeptical About Company’s Growth
On Friday, biopharmaceutical royalty company PDL BioPharma Inc. (NASDAQ:$PDLI) saw its shares soar. It all started after the Nevada-based company reported positive second-quarter earnings. A quarterly net profit that was 827% higher than PDL BioPharma …
Teva Pharmaceutical Posts Second-Quarter Earnings; Shares Drop More Than 18%
On Thursday, in morning trade, Teva Pharmaceutical (TLV:$TEVA) shares dropped more than 18%. It all started after the Petah Tikva, Israel-based company posted lower-than-expected second-quarter earnings.
The multinational pharmaceutical company missed estimates for …
This is Why Pfizer’s Quarterly Revenue Missed Wall Street Expectations
Before the market opened on Tuesday, Pfizer Inc. (NYSE:$PFE) reported its quarterly revenue. Unfortunately, the revenue missed Wall Street estimates. Many speculate the miss in quarterly revenue was caused by a lower demand for Enbrel …
Merck & Company Reported a Quarter Two Earnings Increase
On Friday, July 28, Merck & Company (NYSE:$MRK) announced that its Q2 earnings increased as the drugmaker had blockbuster growth for its cancer drug Keytruda.
Based on the Q2 earnings report, Merck’s new …
Bristol-Myers Reported Q2 Profit Match and Revenue Beat, But Shares Still Fell 6.2%
On July 27, Bristol-Myers Squibb Co. (NYSE:$BMY) reported a Q2 profit match and revenue beat. However, shares fell 6.2% in pre-market trade after AstraZeneca’s late-stage clinical trial failed. Why did this affect the company’s stock? …
Tetraphase Pharmaceuticals Saw an Increase in Shares Today, Here’s Why!
Tetraphase Pharmaceuticals (NASDAQ:$TTPH) saw an increase in shares today. And when I say increase, I mean a whopping 27% increase. It all started after the Watertown, Massachusetts-based company disclosed positive top-line results for a phase …
HCA Healthcare’s Q2 Earnings Report Suggests The Company Has Had a Weak Quarter
Are you looking to invest in healthcare? If so, it’s important for you to know that HCA Healthcare Inc. (NYSE:$HCA), an American operator of healthcare facilities, has had a weak quarter. On Tuesday, in a …